Hyalohyphomycosis: Infection Due to Hyaline Moulds

Hospenthal, Duane R.

doi:10.1007/978-3-319-13090-3_11

Cited by 2 publications

(4 citation statements)

References 60 publications

(73 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…That is why fungi belonging to this group are extremely heterogeneous [4]. Hyalohyphomycosis commonly includes infections caused by species of Fusarium, Scedosporium, Purpureocillium, Acremonium, Penicillium, Scopulariopsis, Trichoderma, and others [7]. Table 1 contains basic information on the epidemiology, infection pathway, disease spectrum, and sensitivity to antifungals of the aforementioned fungi.…”

Section: Hyalohyphomycosismentioning

confidence: 99%

Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients

Ferara,

Špoljar,

Lugović-Mihić

et al. 2024

Life

View full text Add to dashboard Cite

There has been a substantial increase in the number of cases of invasive fungal infections worldwide, which is associated with a growing number of immunosuppressed patients and a rise in antifungal resistance. Some fungi that were previously considered harmless to humans have become emerging pathogens. One of them is Purpureocillium lilacinum, a ubiquitous filamentous fungus commonly found in the environment, especially in the air and soil. P. lilacinum belongs to a bigger group of hyaline fungi that cause hyalohyphomycosis, a fungal infection caused by fungi with colorless hyphae. Although this is a heterogeneous group of fungi, there are similarities regarding their ubiquity, ways of transmission, affected patients, and difficulties in diagnostics and treatment. In hyalohyphomycosis, the skin is one of the most affected organs, which is why the involvement of dermatologists is crucial for the initial assessment, since the timely recognition and early diagnosis of this condition can prevent life-threatening infections and death. In this review, we covered cutaneous hyalohyphomycosis caused by P. lilacinum and other fungi in the same group, including Fusarium, Penicilium, Scedosporium, Scopulariopsis, Acremonium, and Trichoderma genera.

show abstract

Section: Hyalohyphomycosismentioning

confidence: 99%

Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients

Ferara,

Špoljar,

Lugović-Mihić

et al. 2024

Life

View full text Add to dashboard Cite

show abstract

“…( Table S2 ). These fungi cause superficial or localized infections in immunocompetent patients and invasive or disseminated infections in immunocompromised hosts [ 253 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

“…Routes of infection include inhaling aerosolized spores from the soil, polluted waters, and decaying organic materials, entering fungal spores through wounds or other minor skin injuries, and ingesting contaminated food products. Among the reported risk factors are the use of medication (immunosuppressors), underlying medical conditions (HIV/AIDS, autoimmune disorders, transplanted patients, neutropenia, malignancy, liver diseases, kidney diseases), trauma, burns, surgery, and the use of a central venous catheter [ 253 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Manifestations of Human Exposure to Fungi

Oliveira

Lisboa

et al. 2023

JoF

View full text Add to dashboard Cite

Biological particles, along with inorganic gaseous and particulate pollutants, constitute an ever-present component of the atmosphere and surfaces. Among these particles are fungal species colonizing almost all ecosystems, including the human body. Although inoffensive to most people, fungi can be responsible for several health problems, such as allergic fungal diseases and fungal infections. Worldwide fungal disease incidence is increasing, with new emerging fungal diseases appearing yearly. Reasons for this increase are the expansion of life expectancy, the number of immunocompromised patients (immunosuppressive treatments for transplantation, autoimmune diseases, and immunodeficiency diseases), the number of uncontrolled underlying conditions (e.g., diabetes mellitus), and the misusage of medication (e.g., corticosteroids and broad-spectrum antibiotics). Managing fungal diseases is challenging; only four classes of antifungal drugs are available, resistance to these drugs is increasing, and no vaccines have been approved. The present work reviews the implications of fungal particles in human health from allergic diseases (i.e., allergic bronchopulmonary aspergillosis, severe asthma with fungal sensitization, thunderstorm asthma, allergic fungal rhinosinusitis, and occupational lung diseases) to infections (i.e., superficial, subcutaneous, and systemic infections). Topics such as the etiological agent, risk factors, clinical manifestations, diagnosis, and treatment will be revised to improve the knowledge of this growing health concern.

show abstract

Hyalohyphomycosis: Infection Due to Hyaline Moulds

Cited by 2 publications

References 60 publications

Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients

Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients

Clinical Manifestations of Human Exposure to Fungi

Contact Info

Product

Resources

About